Challenge trials are commonly deployed by scientists trying to develop a vaccine and have been used in malaria, typhoid and flu. The group campaigns for Covid-19 infection trials and has enlisted 37,000 people worldwide. hVivo's laboratory in Whitechapel, east London (under construction) where the initial trials are set to be held inWHAT ARE CHALLENGE TRIALS? Scientists behind the challenge trial will have to select and purify a strain of coronavirus that is currently circulating among the UK population. The London trial will initially use remdesivir, an antiviral drug which has shown promise in preliminary studies.

Source: Daily Mail September 23, 2020 15:44 UTC